Next Article in Journal
The Effect of Physical and Chemical Cues on Hepatocellular Function and Morphology
Previous Article in Journal
Polymorphisms in DNA Repair Genes (APEX1, XPD, XRCC1 and XRCC3) and Risk of Preeclampsia in a Mexican Mestizo Population
Article

Detection of Borreliae in Archived Sera from Patients with Clinically Suspect Lyme Disease

1
Department of Pathology, Milford Hospital, 300 Seaside Ave., Milford, CT 06460, USA
2
Therapeutic Research Foundation, Old Saybrook, CT 06475, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2014, 15(3), 4284-4298; https://doi.org/10.3390/ijms15034284
Received: 27 January 2014 / Revised: 1 March 2014 / Accepted: 4 March 2014 / Published: 11 March 2014
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
The diagnoses of Lyme disease based on clinical manifestations, serological findings and detection of infectious agents often contradict each other. We tested 52 blind-coded serum samples, including 20 pre-treatment and 12 post-treatment sera from clinically suspect Lyme disease patients, for the presence of residual Lyme disease infectious agents, using nested PCR amplification of a signature segment of the borrelial 16S ribosomal RNA gene for detection and direct DNA sequencing of the PCR amplicon for molecular validation. These archived sera were split from the samples drawn for the 2-tier serology tests performed by a CDC-approved laboratory, and are used as reference materials for evaluating new diagnostic reagents. Of the 12 post-treatment serum samples, we found DNA evidence of a novel borrelia of uncertain significance in one, which was also positive for the 2-tier serology test. The rest of the post-treatment sera and all 20 control sera were PCR-negative. Of the 20 pre-treatment sera from clinically suspect early Lyme disease patients, we found Borrelia miyamotoi in one which was 2-tier serology-negative, and a Borrelia burgdorferi in two—one negative and one positive for 2-tier serology. We conclude that a sensitive and reliable DNA-based test is needed to support the diagnosis of Lyme disease and Lyme disease-like borreliosis. View Full-Text
Keywords: DNA sequencing; same-nested PCR; 16S rDNA; Lyme borreliosis; novel borrelia; Lyme disease; Borrelia burgdorferi; Borrelia miyamotoi; 2-tier serology DNA sequencing; same-nested PCR; 16S rDNA; Lyme borreliosis; novel borrelia; Lyme disease; Borrelia burgdorferi; Borrelia miyamotoi; 2-tier serology
Show Figures

MDPI and ACS Style

Lee, S.H.; Vigliotti, J.S.; Vigliotti, V.S.; Jones, W.; Shearer, D.M. Detection of Borreliae in Archived Sera from Patients with Clinically Suspect Lyme Disease. Int. J. Mol. Sci. 2014, 15, 4284-4298. https://doi.org/10.3390/ijms15034284

AMA Style

Lee SH, Vigliotti JS, Vigliotti VS, Jones W, Shearer DM. Detection of Borreliae in Archived Sera from Patients with Clinically Suspect Lyme Disease. International Journal of Molecular Sciences. 2014; 15(3):4284-4298. https://doi.org/10.3390/ijms15034284

Chicago/Turabian Style

Lee, Sin H., Jessica S. Vigliotti, Veronica S. Vigliotti, William Jones, and David M. Shearer. 2014. "Detection of Borreliae in Archived Sera from Patients with Clinically Suspect Lyme Disease" International Journal of Molecular Sciences 15, no. 3: 4284-4298. https://doi.org/10.3390/ijms15034284

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop